These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prognostic indicators for the diagnosis of multiple myeloma. Greipp P; Oncology (Williston Park); 2004 May; 18(5):558-60. PubMed ID: 15209186 [TBL] [Abstract][Full Text] [Related]
6. Strategies in treating newly diagnosed or untreated multiple myeloma patients. From the Multiple Myeloma Research Foundation. Weber DM Oncology (Williston Park); 2003 Jun; 17(6):765-7. PubMed ID: 12846120 [TBL] [Abstract][Full Text] [Related]
7. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation. Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH; Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634 [TBL] [Abstract][Full Text] [Related]
8. Amifostine feasibility and efficacy in autologous stem cell transplantation for multiple myeloma. Stocchi R; Damiani D; Masolini P; Michelutti A; Baccarani M; Tosi P; Fanin R Haematologica; 2004 Apr; 89(4):ELT02. PubMed ID: 15075115 [No Abstract] [Full Text] [Related]
9. Newly diagnosed multiple myeloma: allograft or autograft? Gupta D; Kumar L Natl Med J India; 2007; 20(6):300-1. PubMed ID: 18335797 [No Abstract] [Full Text] [Related]
10. Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation. Patriarca F; Prosdocimo S; Tomadini V; Vasciaveo A; Bruno B; Fanin R Haematologica; 2005 Feb; 90(2):278-9. PubMed ID: 15710593 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period. Haas PS; Bauchmüller K; Kühnemund A; Finke J; Ihorst G; Engelhardt M Ann Hematol; 2006 Mar; 85(3):191-3. PubMed ID: 16365747 [No Abstract] [Full Text] [Related]
12. Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis. Slovacek L; Slovackova B; Pavlik V; Hrstka Z; Macingova Z; Jebavy L; Horacek JM Neoplasma; 2008; 55(4):350-5. PubMed ID: 18505348 [TBL] [Abstract][Full Text] [Related]
13. Molecular remission of multiple myeloma with cytoreductive autografting followed by a dose-reduced allograft. Fujikawa K; Nakaseko C; Cho R; Abe D; Oda K; Tanaka H; Ohwada C; Ozawa S; Takeuchi M; Sakaida E; Shimizu N; Naito M; Nishimura M; Saito Y Bone Marrow Transplant; 2007 Nov; 40(10):997-9. PubMed ID: 17724437 [No Abstract] [Full Text] [Related]
14. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma. Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425 [TBL] [Abstract][Full Text] [Related]
15. Thrombotic microangiopathy after combined autografting-allografting for multiple myeloma - report of three cases. Kornacker M; Luft T; Ho AD; Schaefer HJ Eur J Haematol; 2005 Mar; 74(3):250-3. PubMed ID: 15693795 [TBL] [Abstract][Full Text] [Related]
16. An update: health economics of managing multiple myeloma. Moeremans K; Annemans L Eur J Cancer; 2006 Jul; 42(11):1684-91. PubMed ID: 16781867 [TBL] [Abstract][Full Text] [Related]
17. Management of multiple myeloma: the changing landscape. Reece DE Blood Rev; 2007 Nov; 21(6):301-14. PubMed ID: 17761373 [TBL] [Abstract][Full Text] [Related]
18. Autografting followed by a reduced-intensity conditioning unrelated donor cord blood transplantation for a patient with refractory multiple myeloma: successful engraftment with minimal toxicity. Ando T; Yujiri T; Tominaga T; Shinya S; Takahashi T; Nomiyama J; Seguchi M; Matsubara A; Fujii Y; Tanizawa Y Eur J Haematol; 2005 Feb; 74(2):175-9. PubMed ID: 15654912 [TBL] [Abstract][Full Text] [Related]
19. Role of autologous stem-cell transplantation in multiple myeloma. Attal M; Harousseau JL Best Pract Res Clin Haematol; 2007 Dec; 20(4):747-59. PubMed ID: 18070717 [TBL] [Abstract][Full Text] [Related]